Rosticci, M; Marullo, L; Cicero, A F G; Magi, R; Fischer, K; Pervjakova, N; D'Addato, S; Rizzoli, E; Massimo, G; Giovannini, M; Angelini, S; Scapoli, C; Prokopenko, I; Borghi, C, 1A.11: ASSOCIATION OF KIF6 AND HMGCR LOCI WITH CARDIOMETABOLIC PHENOTYPES AND RESPONSE TO STATIN THERAPY IN THE BRISIGHELLA COHORT, «JOURNAL OF HYPERTENSION», 2015, 33, pp. e3 - e4 [Abstract]
Olivieri F;Bonafè M;Spazzafumo L;Gobbi M;Prattichizzo F;Recchioni R;Marcheselli F;La Sala L;Galeazzi R;Rippo MR;Fulgenzi G;Angelini S;Lazzarini R;Bonfigli AR;Brugè F;Tiano L;Genovese S;Ceriello A;Boemi M;Franceschi C;Procopio AD;Testa R, Age- and glycemia-related miR-126-3p levels in plasma and endothelial cells, «AGING», 2014, 6, pp. 771 - 787 [Scientific article]
Maffei F;Zolezzi Moraga JM;Angelini S;Zenesini C;Musti M;Festi D;Cantelli-Forti G;Hrelia P, Micronucleus frequency in human peripheral blood lymphocytes as a biomarker for the early detection of colorectal cancer risk., «MUTAGENESIS», 2014, 29, pp. 221 - 225 [Scientific article]
Di Paolo A;Polillo M;Capecchi M;Cervetti G;Baratè C;Angelini S;Guerrini F;Fontanelli G;Arici R;Ciabatti E;Grassi S;Bocci G;Hrelia P;Danesi R;Petrini M;Galimberti S, The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia., «PHARMACOGENOMICS JOURNAL», 2014, 14, pp. 328 - 335 [Scientific article]
Angelini S; Soverini S; Ravegnini G; Barnett M; Turrini E; Thornquist M; Pane F; Hughes TP; White DL; Radich J; Kim DW; Saglio G; Cilloni D; Iacobucci I; Perini G; Woodman R; Cantelli-Forti G; Baccarani M; Hrelia P; Martinelli G, Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy, «HAEMATOLOGICA», 2013, 98, pp. 193 - 200 [Scientific article]Open Access
Francesca Maffei;Sabrina Angelini;Giorgio Cantelli Forti;Patrizia Hrelia, Blood Biomarkers Linked to Oxidative Stress and Chronic Inflammation for Risk Assessment of Colorectal Neoplasia, «CURRENT COLORECTAL CANCER REPORTS», 2013, 9, pp. 85 - 94 [Scientific article]
Angelini S;Ravegnini G;Fletcher JA;Maffei F;Hrelia P, Clinical relevance of pharmacogenetics in gastrointestinal stromal tumor treatment in the era of personalized therapy., «PHARMACOGENOMICS», 2013, 14, pp. 941 - 956 [Scientific article]
Ravegnini G.; Mariño-Enriquez; Slater J.; Eilers G.; Wang Y.; Zhu M.; Nucci M.R.; George S.; Angelini S.; Raut C.P.; Fletcher J.A., MED12 mutations in Leiomyosarcoma and Extrauterine Leiomyoma, «MODERN PATHOLOGY», 2013, 26, pp. 743 - 749 [Scientific article]
Angelini S; Pantaleo MA; Ravegnini G; Zenesini C; Cavrini G; Nannini M; Fumagalli E; Palassini E; Saponara M; Di Battista M; Casali PG; Hrelia P; Cantelli-Forti G; Biasco G, Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable Gastrointestinal stromal tumours treated with imatinib therapy, «PHARMACOLOGICAL RESEARCH», 2013, 68, pp. 1 - 6 [Scientific article]
S. Angelini; F. Maffei; J.L. Bermejo; G. Ravegnini; D. L’Insalata; G. Cantelli-Forti; F. S. Violante; P. Hrelia, Environmental exposure to benzene, micronucleus formation and
polymorphisms in DNA-repair genes: A pilot study, «MUTATION RESEARCH. GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS», 2012, 743, pp. 99 - 104 [Scientific article]
Angelini S.; Kumar R.; Bermejo J.L.; Maffei F.; Barbieri A.; Graziosi F.; Carbone F.; Cantelli-Forti G.; Violante F.S.; Hemminki K.; Hrelia P., Exposure to low environmental levels of benzene: evaluation of micronucleus frequencies and S-phenylmercapturic acid excretion in relation to polymorphisms in genes encoding metabolic enzymes, «MUTATION RESEARCH. GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS», 2011, 719, pp. 7 - 13 [Scientific article]
ANGELINI S.; M. PANTALEO; E. TURRINI; M. DI BATTISTA; G. CANTELLI FORTI; G. BIASCO; P. HRELIA, Association between genotypes and response to imatinib mesylate treatment in a subset of previously untreated patients affected by gastrointestinal stromal tumours., in: Libro degli Abstracts, s.l, European Science Foundation, 2010, pp. - - - (atti di: European Science Foundation (ESF) Conference - Pharmacogenetics and Pharmacogenomics, S. Feliu de Guixol, Spain, June 6-11, 2010) [Abstract]
ANGELINI S.; S. POVERINI; E. TURRINI; G. PERINI; F. PANE; F. QUARANTELLI; T. HUGHES; D. WHITE; D.W. KIM; H. GOH; J. RADICH; L. BEPPU; G. SAGLIO; D. CILLONI; C. TERRAGNA; I. IACOBUCCI; P. HRELIA; G. CANTELLI FORTI; T. KALEBIC; M. THORNQUIST; M. BACCARANI; G. MARTINELLI, Association between genotypes and response to the treatment in a subset of previously untreated chronic myeloid leukemia patients enrolled into the TOPS trial., in: Libro degli Abstracts, s.l, s.n, 2010, pp. - - - (atti di: 14th International Biotechnology Symposium and Exhibition (IBS), Rimini, Italy, September 14-18, 2010) [Abstract]
Scherer D.; Rachakonda P.S.; Angelini S.; Mehnert F.; Sucker A.; Egberts F.; Hauschild A.; Hemminki K.; Schadendorf D.; Kumar R., Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma Tumors, «JOURNAL OF INVESTIGATIVE DERMATOLOGY», 2010, 130, pp. 2844 - 2848 [Scientific article]
AFFATATO A.A.; M. PAPI; M. VALLI; S. ANGELINI; P. HRELIA; A. RAVAIOLI; G. CANTELLI FORTI, A genetic perspective to the response to pt-based chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: toward a customized chemotherapy., in: Libro degli Abstracts, MILANO, Società Italiana di Farmacologia, 2009, pp. - - - (atti di: 34° Congresso Nazionale della Società Italiana di Farmacologia, Rimini, 14-17 Ottobre 2009) [Abstract]
